Pfizer Boosts Pharmacogenomic Pedigree With $50 Mil. Stake In Perlegen
This article was originally published in The Pink Sheet Daily
Biotech company specializes in identifying genetic markers to predict patient response to drugs.
You may also be interested in...
Companies to engage in four-year research project on genomic markers.
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13